LIPOSOMAL AMPHOTERICIN B (L-AMB) TWICE WEEKLY AS ANTIFUNGAL PROPHYLAXIS IN PEDIACTRIC CANCER PATIENTS

被引：0
|
作者：
Lehrnbecher, Thomas [1 ]
Schedler, Nadine [1 ]
Tramsen, Lars [1 ]
Becker, Martina [1 ]
Klingebiel, Thomas [1 ]
Bochennek, Konrad [1 ]
机构：
[1] Goethe Univ Frankfurt, Frankfurt, Germany
来源：
PEDIATRIC BLOOD & CANCER | 2010年 / 55卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：948 / 949
页数：2
相关论文
共 50 条
  • [21] Efficacy comparison between Liposomal Amphotericin B (L-AmB) and Voriconazole (Vori) in a murine infection model of pulmonary Aspergillus flavus
    Olson, J. A.
    Hahka, D.
    Nguyen, N.
    Adler-Moore, J. P.
    MYCOSES, 2013, 56 : 164 - 164
  • [22] Cost-benefit assessment of antifungal prophylaxis with liposomal amphotericin B in neutropenic patients
    Penack, Olaf
    Reinhold, Thomas
    Thiel, Eckhard
    Blau, Igor Wolfgang
    ONKOLOGIE, 2007, 30 (12): : 621 - 626
  • [23] Pharmacokinetics of high-dose weekly ambisome (liposomal amphotericin B) antifungal prophylaxis in pediatric bone marrow transplantation (BMT) patients
    Mehta, PA
    Vinks, AA
    Filipovich, AH
    Vaughn, GA
    Fearing, DN
    Sper, C
    Davies, SM
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 89 - 89
  • [24] High-dose Weekly Liposomal Amphotericin B Antifungal Prophylaxis in Patients Undergoing Liver Transplantation: A Prospective Phase II Trial
    Giannella, Maddalena
    Ercolani, Giorgio
    Cristini, Francesco
    Morelli, Mariacristina
    Bartoletti, Michele
    Bertuzzo, Valentina
    Tedeschi, Sara
    Faenza, Stefano
    Puggioli, Cristina
    Lewis, Russell E.
    Pinna, Antonio Daniele
    Viale, Pierluigi
    TRANSPLANTATION, 2015, 99 (04) : 848 - 854
  • [25] SAFETY AND EFFICACY OF LOW DOSE LIPOSOMAL AMPHOTERICIN B (L-AMB) FOLLOWED BY MICAFUNGIN PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS (IFI) IN PEDIATRIC ALLOGENEIC STEM CELL TRANSPLANTATION (ALLOSCT) RECIPIENTS
    Elmacken, Mona
    Ours, Christopher
    Mitchell, Daniel
    Militano, Olga
    Vandeven, Carmella
    Cairo, Mitchell
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S104 - S104
  • [26] Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis
    Lanternier, F.
    Poiree, S.
    Elie, C.
    Garcia-Hermoso, D.
    Bakouboula, P.
    Sitbon, K.
    Herbrecht, R.
    Wolff, M.
    Ribaud, P.
    Lortholary, O.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (11) : 3116 - 3123
  • [27] Weekly liposomal amphotericin B as secondary prophylaxis for invasive fungal infections in patients with hematological malignancies
    Cahuayme-Zuniga, Lizbeth
    Lewis, Russell E.
    Mulanovich, Victor E.
    Kontoyiannis, Dimitrios P.
    MEDICAL MYCOLOGY, 2012, 50 (05) : 543 - 548
  • [28] Efficacy outcomes in a randomized trial of liposomal amphotericin B (L-AMB) based on Revised EORTC/MSG 2008 definitions of invasive fungal disease (IFD)
    Cornely, O. A.
    Maertens, J.
    Bresnik, M.
    Ebrahimi, R.
    Dellow, E.
    Herbrecht, R.
    Donnelly, P. J.
    MYCOSES, 2009, 52 : 83 - 83
  • [29] Safety of a weekly administration of 10 mg/kg of liposomal amphotericin B for antifungal prophylaxis in allogeneic stem cell transplant and acute leukaemia patients
    Cordonnier, C
    Mohty, M
    Faucher, C
    Vey, N
    Pautas, C
    Robin, M
    Mahi, L
    Ribaud, P
    BONE MARROW TRANSPLANTATION, 2006, 37 : S178 - S178
  • [30] Antifungal therapy in thoracic cancer patients with low dose liposomal amphotericin B (AmBisome)
    Lequaglie, C
    Giudice, G
    Massone, PPB
    Cataldo, I
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (04) : 541 - 543
12345